Histological study of prostatic cancer. Prognostic and therapeutic value
Bouffioux, C.
Journal d'Urologie et de Nephrologie 80(12 Part 2): 531-540
1974
ISSN/ISBN: 0021-8200 PMID: 4469333 Document Number: 80171
Document emailed within 1 workday
Related Documents
Studer, U.E. 1988: Prognostic and therapeutic aspects of prostatic carcinoma Schweizerische Rundschau für Medizin Praxis 77(20): 545-550Nagel, R. 1980: Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
Medvedev, V.L.; Matsionis, A.E.; Medvedeva, L.A. 2003: Clinical significance of histological types of prostatic cancer Urologiia 6: 10-14
Chisholm, G.D. 1984: Prostatic cancer: prognostic criteria Turkish Journal of Pediatrics 26(1-4): 265-266
Drukin, E.I.; Karaseva, N.A. 1985: Histological structure and tumor size as prognostic factors in the surgical treatment of patients with peripheral lung cancer Vestnik Khirurgii Imeni I. I. Grekova 135(9): 14-17
Yamanaka, H.; Shida, K. 1984: Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 537-544
Fridman, W.H.; Berger, A.; Cugnenc, P.H.; Tartour, E. 1997: Cytokines as prognostic and therapeutic tools in human cancer European Cytokine Network 8(3): 321-322
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oliva, V.; Berardi, T.; Punzo, C.; Giardina, C.; De Leo, G.; Cirilli, A. 1986: Prognostic and therapeutic implications of axillary metastases in breast cancer Minerva Chirurgica 41(5-6): 425-430
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Chime-Udeh, E. 1991: Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2) Connecticut Medicine 55(9): 526-528
Diaconescu, M.R.; Vexler, L.; Costea, I.; Brănişteanu, I.; Glod, M. 1997: A prognostic audit in colorectal cancer: between the clinical realities and the therapeutic principles Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 101(1-2): 174-178
Robbins, K.T. 1988: Prognostic and therapeutic implications of gender and menopausal status in laryngeal cancer Journal of Otolaryngology 17(2): 81-85
Soulié, M.; Villers, A.; Richaud, P.; Prapotnich, D.; Ruffion, A.; Grosclaude, P. 2001: Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 11(6): 1195-1204
Sarré, B.; Ogougbèmy, M.; Dotou, C.; Lopy, J.; Ndionne, P.; Frank, K.; Drave, K.; Diouf, M.B. 2006: Epidemiological, therapeutic and prognostic aspects of breast cancer: about 473 cases collected in Hopital Principal de Dakar Dakar Medical 51(2): 92-96
Petter, G.; Haustein, U.F. 1999: Histological and clinical prognostic factors in squamous cell carcinoma of the skin. A contribution to the multicenter carcinoma study of the association of surgical and oncological dermatology Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 50(6): 412-417
Kudo, K.; Nagata, M.; Hayashi, N.; Imamura, H.; Iwamoto, K.; Kimura, M.; Matsubara, M.; Mimura, H.; Matsuyama, K.; Suwa, J. 1989: Clinical study of prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(8): 1339-1345
Böcking, A.; Sinagowitz, E.; Thon, W.; Nattenmüller, E.; Wagner, J.; Sandritter, W. 1979: Histological staging of prostatic carcinoma Die Medizinische Welt 30(8): 275-279
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302